nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—chronic obstructive pulmonary disease	0.292	0.851	CbGaD
Acetylsalicylic acid—migraine—Prednisone—chronic obstructive pulmonary disease	0.16	0.508	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.155	0.492	CpDpCtD
Acetylsalicylic acid—ALB—chronic obstructive pulmonary disease	0.0508	0.148	CbGaD
Acetylsalicylic acid—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0307	0.184	CbGbCtD
Acetylsalicylic acid—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0196	0.117	CbGbCtD
Acetylsalicylic acid—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0196	0.117	CbGbCtD
Acetylsalicylic acid—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0177	0.106	CbGbCtD
Acetylsalicylic acid—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0163	0.0975	CbGbCtD
Acetylsalicylic acid—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0163	0.0975	CbGbCtD
Acetylsalicylic acid—ALB—Prednisone—chronic obstructive pulmonary disease	0.0127	0.076	CbGbCtD
Acetylsalicylic acid—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0123	0.0739	CbGbCtD
Acetylsalicylic acid—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00823	0.0492	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00703	0.0421	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00664	0.0397	CbGbCtD
Acetylsalicylic acid—Varicella—Montelukast—chronic obstructive pulmonary disease	0.00353	0.0559	CcSEcCtD
Acetylsalicylic acid—Diuresis—Aminophylline—chronic obstructive pulmonary disease	0.00207	0.0328	CcSEcCtD
Acetylsalicylic acid—Haemorrhagic disorder—Montelukast—chronic obstructive pulmonary disease	0.00189	0.03	CcSEcCtD
Acetylsalicylic acid—Gastric irritation—Aminophylline—chronic obstructive pulmonary disease	0.00165	0.0262	CcSEcCtD
Acetylsalicylic acid—TP53—respiratory system—chronic obstructive pulmonary disease	0.00153	0.0417	CbGeAlD
Acetylsalicylic acid—NFKBIA—respiratory system—chronic obstructive pulmonary disease	0.00151	0.0411	CbGeAlD
Acetylsalicylic acid—HSPA5—respiratory system—chronic obstructive pulmonary disease	0.00148	0.0402	CbGeAlD
Acetylsalicylic acid—TP53—connective tissue—chronic obstructive pulmonary disease	0.00135	0.0368	CbGeAlD
Acetylsalicylic acid—NFKBIA—connective tissue—chronic obstructive pulmonary disease	0.00133	0.0362	CbGeAlD
Acetylsalicylic acid—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.00131	0.0207	CcSEcCtD
Acetylsalicylic acid—HSPA5—connective tissue—chronic obstructive pulmonary disease	0.0013	0.0354	CbGeAlD
Acetylsalicylic acid—TP53—bronchus—chronic obstructive pulmonary disease	0.00126	0.0344	CbGeAlD
Acetylsalicylic acid—RPS6KA3—respiratory system—chronic obstructive pulmonary disease	0.00126	0.0343	CbGeAlD
Acetylsalicylic acid—NFKBIA—bronchus—chronic obstructive pulmonary disease	0.00124	0.0338	CbGeAlD
Acetylsalicylic acid—TP53—smooth muscle tissue—chronic obstructive pulmonary disease	0.00123	0.0336	CbGeAlD
Acetylsalicylic acid—Metabolic acidosis—Formoterol—chronic obstructive pulmonary disease	0.00123	0.0196	CcSEcCtD
Acetylsalicylic acid—Metabolic acidosis—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.0196	CcSEcCtD
Acetylsalicylic acid—Epigastric discomfort—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.0193	CcSEcCtD
Acetylsalicylic acid—HSPA5—bronchus—chronic obstructive pulmonary disease	0.00122	0.0331	CbGeAlD
Acetylsalicylic acid—NFKBIA—smooth muscle tissue—chronic obstructive pulmonary disease	0.00121	0.0331	CbGeAlD
Acetylsalicylic acid—HSPA5—smooth muscle tissue—chronic obstructive pulmonary disease	0.00119	0.0324	CbGeAlD
Acetylsalicylic acid—PTGS2—leg—chronic obstructive pulmonary disease	0.00119	0.0324	CbGeAlD
Acetylsalicylic acid—Metabolic acidosis—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.0185	CcSEcCtD
Acetylsalicylic acid—TP53—trachea—chronic obstructive pulmonary disease	0.00113	0.0309	CbGeAlD
Acetylsalicylic acid—NFKBIA—trachea—chronic obstructive pulmonary disease	0.00111	0.0304	CbGeAlD
Acetylsalicylic acid—RPS6KA3—connective tissue—chronic obstructive pulmonary disease	0.00111	0.0302	CbGeAlD
Acetylsalicylic acid—HSPA5—trachea—chronic obstructive pulmonary disease	0.00109	0.0297	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bronchus—chronic obstructive pulmonary disease	0.00104	0.0282	CbGeAlD
Acetylsalicylic acid—Peptic ulcer—Aminophylline—chronic obstructive pulmonary disease	0.000958	0.0152	CcSEcCtD
Acetylsalicylic acid—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.000939	0.0149	CcSEcCtD
Acetylsalicylic acid—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.000931	0.0148	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—trachea—chronic obstructive pulmonary disease	0.00093	0.0253	CbGeAlD
Acetylsalicylic acid—IKBKB—respiratory system—chronic obstructive pulmonary disease	0.000929	0.0253	CbGeAlD
Acetylsalicylic acid—Haematemesis—Aminophylline—chronic obstructive pulmonary disease	0.000922	0.0146	CcSEcCtD
Acetylsalicylic acid—EDNRA—bronchus—chronic obstructive pulmonary disease	0.000842	0.0229	CbGeAlD
Acetylsalicylic acid—Foetor hepaticus—Montelukast—chronic obstructive pulmonary disease	0.000842	0.0133	CcSEcCtD
Acetylsalicylic acid—IKBKB—connective tissue—chronic obstructive pulmonary disease	0.000818	0.0223	CbGeAlD
Acetylsalicylic acid—TP53—lung—chronic obstructive pulmonary disease	0.000814	0.0222	CbGeAlD
Acetylsalicylic acid—NFKBIA—lung—chronic obstructive pulmonary disease	0.000801	0.0218	CbGeAlD
Acetylsalicylic acid—HSPA5—lung—chronic obstructive pulmonary disease	0.000785	0.0214	CbGeAlD
Acetylsalicylic acid—IKBKB—bronchus—chronic obstructive pulmonary disease	0.000765	0.0208	CbGeAlD
Acetylsalicylic acid—EDNRA—trachea—chronic obstructive pulmonary disease	0.000756	0.0206	CbGeAlD
Acetylsalicylic acid—IKBKB—smooth muscle tissue—chronic obstructive pulmonary disease	0.000748	0.0204	CbGeAlD
Acetylsalicylic acid—Liver disorder—Montelukast—chronic obstructive pulmonary disease	0.000701	0.0111	CcSEcCtD
Acetylsalicylic acid—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.000669	0.0106	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—lung—chronic obstructive pulmonary disease	0.000668	0.0182	CbGeAlD
Acetylsalicylic acid—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00956	CcSEcCtD
Acetylsalicylic acid—Coagulopathy—Salbutamol—chronic obstructive pulmonary disease	0.000591	0.00938	CcSEcCtD
Acetylsalicylic acid—Coma—Aminophylline—chronic obstructive pulmonary disease	0.000585	0.00928	CcSEcCtD
Acetylsalicylic acid—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.000573	0.00909	CcSEcCtD
Acetylsalicylic acid—TP53—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.000559	0.546	CbGdCrCtD
Acetylsalicylic acid—Contusion—Montelukast—chronic obstructive pulmonary disease	0.000547	0.00868	CcSEcCtD
Acetylsalicylic acid—EDNRA—lung—chronic obstructive pulmonary disease	0.000543	0.0148	CbGeAlD
Acetylsalicylic acid—Polyuria—Aminophylline—chronic obstructive pulmonary disease	0.00053	0.0084	CcSEcCtD
Acetylsalicylic acid—Gout—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00828	CcSEcCtD
Acetylsalicylic acid—Gout—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00828	CcSEcCtD
Acetylsalicylic acid—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00052	0.00825	CcSEcCtD
Acetylsalicylic acid—Gastric irritation—Prednisone—chronic obstructive pulmonary disease	0.000495	0.00785	CcSEcCtD
Acetylsalicylic acid—IKBKB—lung—chronic obstructive pulmonary disease	0.000493	0.0134	CbGeAlD
Acetylsalicylic acid—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.000478	0.00757	CcSEcCtD
Acetylsalicylic acid—Melaena—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00755	CcSEcCtD
Acetylsalicylic acid—Melaena—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00755	CcSEcCtD
Acetylsalicylic acid—TP53—Danazol—Prednisone—chronic obstructive pulmonary disease	0.000465	0.454	CbGdCrCtD
Acetylsalicylic acid—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.000423	0.00671	CcSEcCtD
Acetylsalicylic acid—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00653	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Prednisolone—chronic obstructive pulmonary disease	0.000395	0.00626	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00609	CcSEcCtD
Acetylsalicylic acid—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000384	0.00608	CcSEcCtD
Acetylsalicylic acid—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000377	0.00598	CcSEcCtD
Acetylsalicylic acid—Epigastric discomfort—Prednisone—chronic obstructive pulmonary disease	0.000365	0.00579	CcSEcCtD
Acetylsalicylic acid—Thirst—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00578	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00575	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00575	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00543	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00511	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00511	CcSEcCtD
Acetylsalicylic acid—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000309	0.00841	CbGeAlD
Acetylsalicylic acid—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00485	CcSEcCtD
Acetylsalicylic acid—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00485	CcSEcCtD
Acetylsalicylic acid—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00485	CcSEcCtD
Acetylsalicylic acid—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00485	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00482	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000302	0.00478	CcSEcCtD
Acetylsalicylic acid—Asthma—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00475	CcSEcCtD
Acetylsalicylic acid—Influenza—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00475	CcSEcCtD
Acetylsalicylic acid—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000299	0.00473	CcSEcCtD
Acetylsalicylic acid—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000295	0.00804	CbGeAlD
Acetylsalicylic acid—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00458	CcSEcCtD
Acetylsalicylic acid—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00458	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00455	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000282	0.00448	CcSEcCtD
Acetylsalicylic acid—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000272	0.00432	CcSEcCtD
Acetylsalicylic acid—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000272	0.00741	CbGeAlD
Acetylsalicylic acid—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00424	CcSEcCtD
Acetylsalicylic acid—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.00026	0.00708	CbGeAlD
Acetylsalicylic acid—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00408	CcSEcCtD
Acetylsalicylic acid—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00408	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000253	0.004	CcSEcCtD
Acetylsalicylic acid—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000249	0.00678	CbGeAlD
Acetylsalicylic acid—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00391	CcSEcCtD
Acetylsalicylic acid—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000243	0.00662	CbGeAlD
Acetylsalicylic acid—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000243	0.00385	CcSEcCtD
Acetylsalicylic acid—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000241	0.00383	CcSEcCtD
Acetylsalicylic acid—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000238	0.00648	CbGeAlD
Acetylsalicylic acid—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000237	0.00376	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000234	0.00372	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00368	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000232	0.00368	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00367	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000229	0.00362	CcSEcCtD
Acetylsalicylic acid—PTGS1—trachea—chronic obstructive pulmonary disease	0.000228	0.00622	CbGeAlD
Acetylsalicylic acid—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00362	CcSEcCtD
Acetylsalicylic acid—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000227	0.00359	CcSEcCtD
Acetylsalicylic acid—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00357	CcSEcCtD
Acetylsalicylic acid—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000225	0.00356	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000225	0.00356	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000223	0.00354	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.00349	CcSEcCtD
Acetylsalicylic acid—Contusion—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00349	CcSEcCtD
Acetylsalicylic acid—PTGS2—trachea—chronic obstructive pulmonary disease	0.000218	0.00594	CbGeAlD
Acetylsalicylic acid—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000218	0.00346	CcSEcCtD
Acetylsalicylic acid—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000216	0.00343	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000216	0.00342	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00342	CcSEcCtD
Acetylsalicylic acid—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.0034	CcSEcCtD
Acetylsalicylic acid—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.00336	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00334	CcSEcCtD
Acetylsalicylic acid—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000204	0.00323	CcSEcCtD
Acetylsalicylic acid—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00322	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000201	0.00319	CcSEcCtD
Acetylsalicylic acid—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00311	CcSEcCtD
Acetylsalicylic acid—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00311	CcSEcCtD
Acetylsalicylic acid—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00309	CcSEcCtD
Acetylsalicylic acid—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00309	CcSEcCtD
Acetylsalicylic acid—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00304	CcSEcCtD
Acetylsalicylic acid—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00302	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.00301	CcSEcCtD
Acetylsalicylic acid—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00293	CcSEcCtD
Acetylsalicylic acid—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00292	CcSEcCtD
Acetylsalicylic acid—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00292	CcSEcCtD
Acetylsalicylic acid—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00292	CcSEcCtD
Acetylsalicylic acid—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000183	0.00498	CbGeAlD
Acetylsalicylic acid—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000182	0.00288	CcSEcCtD
Acetylsalicylic acid—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00288	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00288	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00288	CcSEcCtD
Acetylsalicylic acid—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00288	CcSEcCtD
Acetylsalicylic acid—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00287	CcSEcCtD
Acetylsalicylic acid—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00287	CcSEcCtD
Acetylsalicylic acid—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00286	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000178	0.00282	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.0028	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00276	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00276	CcSEcCtD
Acetylsalicylic acid—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00275	CcSEcCtD
Acetylsalicylic acid—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00272	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00272	CcSEcCtD
Acetylsalicylic acid—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000171	0.00271	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00017	0.0027	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00269	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00269	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00267	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00264	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.0026	CcSEcCtD
Acetylsalicylic acid—PTGS1—lung—chronic obstructive pulmonary disease	0.000164	0.00447	CbGeAlD
Acetylsalicylic acid—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00256	CcSEcCtD
Acetylsalicylic acid—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00256	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00254	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00254	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00252	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00252	CcSEcCtD
Acetylsalicylic acid—PTGS2—lung—chronic obstructive pulmonary disease	0.000157	0.00427	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00248	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00247	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00246	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00246	CcSEcCtD
Acetylsalicylic acid—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00245	CcSEcCtD
Acetylsalicylic acid—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00245	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00243	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00243	CcSEcCtD
Acetylsalicylic acid—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00242	CcSEcCtD
Acetylsalicylic acid—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000151	0.0024	CcSEcCtD
Acetylsalicylic acid—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.0024	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00238	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00232	CcSEcCtD
Acetylsalicylic acid—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00232	CcSEcCtD
Acetylsalicylic acid—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000145	0.0023	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00229	CcSEcCtD
Acetylsalicylic acid—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00229	CcSEcCtD
Acetylsalicylic acid—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000144	0.00228	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000144	0.00228	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00227	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00227	CcSEcCtD
Acetylsalicylic acid—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000143	0.00226	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00221	CcSEcCtD
Acetylsalicylic acid—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00219	CcSEcCtD
Acetylsalicylic acid—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00219	CcSEcCtD
Acetylsalicylic acid—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000137	0.00217	CcSEcCtD
Acetylsalicylic acid—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000136	0.00215	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000136	0.00215	CcSEcCtD
Acetylsalicylic acid—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.00215	CcSEcCtD
Acetylsalicylic acid—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00215	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00215	CcSEcCtD
Acetylsalicylic acid—ABCB1—trachea—chronic obstructive pulmonary disease	0.000135	0.00368	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00211	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.0021	CcSEcCtD
Acetylsalicylic acid—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00207	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00203	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00203	CcSEcCtD
Acetylsalicylic acid—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.00203	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00201	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00199	CcSEcCtD
Acetylsalicylic acid—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00195	CcSEcCtD
Acetylsalicylic acid—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00195	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00192	CcSEcCtD
Acetylsalicylic acid—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00191	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00189	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00189	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000117	0.00185	CcSEcCtD
Acetylsalicylic acid—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00184	CcSEcCtD
Acetylsalicylic acid—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00182	CcSEcCtD
Acetylsalicylic acid—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00182	CcSEcCtD
Acetylsalicylic acid—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00179	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00178	CcSEcCtD
Acetylsalicylic acid—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.00175	CcSEcCtD
Acetylsalicylic acid—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000111	0.00175	CcSEcCtD
Acetylsalicylic acid—Rash—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00174	CcSEcCtD
Acetylsalicylic acid—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00174	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00174	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00174	CcSEcCtD
Acetylsalicylic acid—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00172	CcSEcCtD
Acetylsalicylic acid—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00172	CcSEcCtD
Acetylsalicylic acid—Rash—Montelukast—chronic obstructive pulmonary disease	0.000107	0.0017	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000107	0.0017	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00167	CcSEcCtD
Acetylsalicylic acid—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00166	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00164	CcSEcCtD
Acetylsalicylic acid—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00164	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00164	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.00164	CcSEcCtD
Acetylsalicylic acid—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00164	CcSEcCtD
Acetylsalicylic acid—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00164	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.00161	CcSEcCtD
Acetylsalicylic acid—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000101	0.0016	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.00159	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.97e-05	0.00158	CcSEcCtD
Acetylsalicylic acid—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.76e-05	0.00155	CcSEcCtD
Acetylsalicylic acid—ABCB1—lung—chronic obstructive pulmonary disease	9.7e-05	0.00264	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.68e-05	0.00154	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.64e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.42e-05	0.00149	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisolone—chronic obstructive pulmonary disease	9.27e-05	0.00147	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.19e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.11e-05	0.00144	CcSEcCtD
Acetylsalicylic acid—Flushing—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.00142	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.76e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Agitation—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.54e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.48e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.14e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.94e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.23e-05	0.000988	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.000955	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisolone—chronic obstructive pulmonary disease	5.94e-05	0.000942	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.93e-05	0.000941	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.64e-05	0.000894	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.6e-05	0.000887	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.44e-05	0.000862	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.04e-05	0.0008	CcSEcCtD
Acetylsalicylic acid—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000768	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000743	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000718	CcSEcCtD
Acetylsalicylic acid—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.00069	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisone—chronic obstructive pulmonary disease	4.32e-05	0.000684	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.31e-05	0.000684	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.000645	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.02e-05	0.000138	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.02e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.02e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.01e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TLR2—chronic obstructive pulmonary disease	1e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.96e-06	0.000134	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.86e-06	0.000133	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.75e-06	0.000131	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	9.67e-06	0.00013	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	9.61e-06	0.000129	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KL—chronic obstructive pulmonary disease	9.4e-06	0.000127	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	9.4e-06	0.000127	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.3e-06	0.000125	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.25e-06	0.000125	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9.24e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.23e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.22e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.22e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	9.22e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL6—chronic obstructive pulmonary disease	9.22e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—IL6—chronic obstructive pulmonary disease	9.2e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	9.19e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.17e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.17e-06	0.000123	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.16e-06	0.000123	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.16e-06	0.000123	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—chronic obstructive pulmonary disease	9.09e-06	0.000122	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.06e-06	0.000122	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	9.05e-06	0.000122	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL1B—chronic obstructive pulmonary disease	9.04e-06	0.000122	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GC—chronic obstructive pulmonary disease	9e-06	0.000121	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.99e-06	0.000121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.94e-06	0.00012	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.94e-06	0.00012	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.82e-06	0.000119	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.82e-06	0.000119	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.58e-06	0.000116	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	8.48e-06	0.000114	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.41e-06	0.000113	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.36e-06	0.000113	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.32e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.3e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.29e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.24e-06	0.000111	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.23e-06	0.000111	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.2e-06	0.00011	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.2e-06	0.00011	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.15e-06	0.00011	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—chronic obstructive pulmonary disease	8.12e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.1e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TGFB1—chronic obstructive pulmonary disease	8.1e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1B—chronic obstructive pulmonary disease	8.08e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	8.08e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EGFR—chronic obstructive pulmonary disease	7.94e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.92e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	7.88e-06	0.000106	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.65e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.61e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD8A—chronic obstructive pulmonary disease	7.58e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.57e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.57e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.51e-06	0.000101	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.51e-06	0.000101	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	7.36e-06	9.92e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.33e-06	9.87e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	7.2e-06	9.7e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.19e-06	9.69e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.17e-06	9.66e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.11e-06	9.58e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—chronic obstructive pulmonary disease	7.08e-06	9.54e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.05e-06	9.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB3—chronic obstructive pulmonary disease	7.05e-06	9.49e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.98e-06	9.4e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.9e-06	9.3e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EGFR—chronic obstructive pulmonary disease	6.89e-06	9.28e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.88e-06	9.27e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.87e-06	9.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.85e-06	9.22e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.79e-06	9.14e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.74e-06	9.08e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.74e-06	9.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.7e-06	9.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.66e-06	8.98e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	6.65e-06	8.96e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	6.57e-06	8.84e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.55e-06	8.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.54e-06	8.8e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	6.45e-06	8.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CRP—chronic obstructive pulmonary disease	6.44e-06	8.68e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.43e-06	8.66e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.43e-06	8.66e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.36e-06	8.57e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.29e-06	8.47e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.18e-06	8.32e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TLR4—chronic obstructive pulmonary disease	6.18e-06	8.32e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EGFR—chronic obstructive pulmonary disease	6.16e-06	8.29e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.14e-06	8.27e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.14e-06	8.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	6.11e-06	8.22e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—chronic obstructive pulmonary disease	6.1e-06	8.22e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	6.1e-06	8.21e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.09e-06	8.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.08e-06	8.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.08e-06	8.18e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.02e-06	8.11e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	6.01e-06	8.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.01e-06	8.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.98e-06	8.06e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	5.92e-06	7.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.9e-06	7.94e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.67e-06	7.64e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KL—chronic obstructive pulmonary disease	5.67e-06	7.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.61e-06	7.56e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.61e-06	7.55e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.6e-06	7.54e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.56e-06	7.49e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.51e-06	7.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.48e-06	7.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.46e-06	7.35e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.45e-06	7.34e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.45e-06	7.33e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.45e-06	7.33e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.3e-06	7.14e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—chronic obstructive pulmonary disease	5.29e-06	7.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EGFR—chronic obstructive pulmonary disease	5.26e-06	7.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.23e-06	7.05e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.18e-06	6.97e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.18e-06	6.97e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.05e-06	6.8e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	5.05e-06	6.8e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.01e-06	6.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	4.99e-06	6.72e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.95e-06	6.67e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.95e-06	6.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.94e-06	6.66e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.93e-06	6.63e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.93e-06	6.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.92e-06	6.62e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.89e-06	6.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	4.89e-06	6.58e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.87e-06	6.57e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	4.86e-06	6.54e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	4.76e-06	6.41e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—chronic obstructive pulmonary disease	4.73e-06	6.37e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.67e-06	6.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.62e-06	6.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.56e-06	6.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.55e-06	6.13e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.54e-06	6.12e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.49e-06	6.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	4.46e-06	6.01e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.45e-06	6e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	4.43e-06	5.97e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.42e-06	5.96e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.42e-06	5.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.41e-06	5.94e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.4e-06	5.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.38e-06	5.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	4.36e-06	5.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.31e-06	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.27e-06	5.76e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.26e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	4.25e-06	5.72e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.21e-06	5.67e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.15e-06	5.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.11e-06	5.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.09e-06	5.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.08e-06	5.49e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.07e-06	5.48e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.06e-06	5.47e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.06e-06	5.47e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.04e-06	5.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.02e-06	5.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—chronic obstructive pulmonary disease	4.02e-06	5.41e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.98e-06	5.36e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.98e-06	5.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	3.98e-06	5.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.98e-06	5.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.88e-06	5.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.87e-06	5.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.77e-06	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.74e-06	5.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.71e-06	4.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.67e-06	4.94e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.67e-06	4.94e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.63e-06	4.89e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.58e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	3.54e-06	4.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.43e-06	4.62e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.43e-06	4.62e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.42e-06	4.61e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.41e-06	4.59e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.38e-06	4.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.38e-06	4.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.36e-06	4.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.34e-06	4.5e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.34e-06	4.5e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.34e-06	4.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.2e-06	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.15e-06	4.24e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.15e-06	4.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	3.14e-06	4.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.13e-06	4.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—chronic obstructive pulmonary disease	3.06e-06	4.12e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.06e-06	4.12e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.06e-06	4.12e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.06e-06	4.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.05e-06	4.11e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.02e-06	4.06e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	3e-06	4.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.99e-06	4.02e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.99e-06	4.02e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	2.98e-06	4.02e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.97e-06	4e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.94e-06	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	2.85e-06	3.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.81e-06	3.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.79e-06	3.76e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.75e-06	3.7e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.74e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.71e-06	3.65e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.66e-06	3.59e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.6e-06	3.5e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	2.59e-06	3.49e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.56e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	2.49e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.45e-06	3.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.43e-06	3.27e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.39e-06	3.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—chronic obstructive pulmonary disease	2.35e-06	3.17e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.2e-06	2.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	2.03e-06	2.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.02e-06	2.72e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.98e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.94e-06	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.93e-06	2.6e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	1.88e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	1.85e-06	2.49e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.81e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.77e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.73e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.69e-06	2.28e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.66e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.65e-06	2.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.58e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.52e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	1.42e-06	1.91e-05	CbGpPWpGaD
